Interleukin 19 reduces inflammation in chemically induced experimental colitis

International Immunopharmacology

Volumn 29, Issue 2, 2015, Pages 468-475

  Matsuo, Yukiko ^a   Azuma, Yasu Taka ^a   Kuwamura, Mitsuru ^a   Kuramoto, Nobuyuki ^b   Nishiyama, Kazuhiro ^a   Yoshida, Natsuho ^a   Ikeda, Yoshihito ^a   Fujimoto, Yasuyuki ^a   Nakajima, Hidemitsu ^a   Takeuchi, Tadayoshi ^a  

^a Osaka City University   (Japan)

^b SETSUNAN UNIVERSITY   (Japan)

Author keywords

Anti inflammatory cytokine; Colitis; IL 19; Inflammatory bowel disease

Indexed keywords

CXCL1 CHEMOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 19; INTERLEUKIN 22; INTERLEUKIN 33; INTERLEUKIN 4; RANTES; TRINITROBENZENESULFONIC ACID; CYTOKINE; IL19 PROTEIN, MOUSE; INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DESCENDING COLON; DISEASE EXACERBATION; EXPERIMENTAL COLITIS; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; C57BL MOUSE; CHEMICALLY INDUCED; COLITIS; CONVALESCENCE; CROHN DISEASE; GENETICS; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; PATHOLOGY;

ANIMALS; COLITIS; CROHN DISEASE; CYTOKINES; INFLAMMATION; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECOVERY OF FUNCTION; T-LYMPHOCYTES; TRINITROBENZENESULFONIC ACID;

EID: 84948458585     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.10.011     Document Type: Article

References (39)

1. M. Tong, X. Li, L. Wegener Parfrey, B. Roth, A. Ippoliti, B. Wei, and et al. A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease PLoS One 8 2013 e80702
2. M.C. Li, and S.H. He IL-10 and its related cytokines for treatment of inflammatory bowel disease World J. Gastroenterol. 10 2004 620 625
3. M. Mahler, and E.H. Leiter Genetic and environmental context determines the course of colitis developing in IL-10-deficient mice Inflamm. Bowel Dis. 8 2002 347 355
4. R. Sabat, E. Wallace, S. Endesfelder, and K. Wolk IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases Expert Opin. Ther. Targets 11 2007 601 612
5. Y.T. Azuma, H. Nakajima, and T. Takeuchi IL-19 as a potential therapeutic in autoimmune and inflammatory diseases Curr. Pharm. Des. 17 2011 3776 3780
6. G. Gallagher, H. Dickensheets, J. Eskdale, L.S. Izotova, O.V. Mirochnitchenko, J.D. Peat, and et al. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10) Genes Immun 1 2000 442 450
7. Y.C. Liao, W.G. Liang, F.W. Chen, J.H. Hsu, J.J. Yang, and M.S. Chang IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha J. Immunol. 169 2002 4288 4297
8. G. Gallagher, J. Eskdale, W. Jordan, J. Peat, J. Campbell, M. Boniotto, and et al. Human interleukin-19 and its receptor: a potential role in the induction of Th2 responses Int. Immunopharmacol. 4 2004 615 626
9. S.C. Liao, Y.C. Cheng, Y.C. Wang, C.W. Wang, S.M. Yang, C.K. Yu, and et al. IL-19 induced Th2 cytokines and was up-regulated in asthma patients J. Immunol. 173 2004 6712 6718
10. K. Otkjaer, K. Kragballe, A.T. Funding, J.T. Clausen, P.L. Noerby, T. Steiniche, and et al. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis Br J Dermatol 153 2005 911 918
11. J.R. Chan, W. Blumenschein, E. Murphy, C. Diveu, M. Wiekowski, S. Abbondanzo, and et al. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis J Exp Med 203 2006 2577 2587
12. S.M. Sa, P.A. Valdez, J. Wu, K. Jung, F. Zhong, L. Hall, and et al. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis J. Immunol. 178 2007 2229 2240
13. Y.T. Azuma, Y. Matsuo, M. Kuwamura, G.D. Yancopoulos, D.M. Valenzuela, A.J. Murphy, and et al. Interleukin-19 protects mice from innate-mediated colonic inflammation Inflamm. Bowel Dis. 16 2010 1017 1028
14. G. Monteleone, I. Monteleone, D. Fina, P. Vavassori, B.G. Del Vecchio, R. Caruso, and et al. Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease Gastroenterology 128 2005 687 694
15. J. Tanaka, K. Saga, M. Kido, H. Nishiura, T. Akamatsu, T. Chiba, and et al. Proinflammatory Th2 cytokines induce production of thymic stromal lymphopoietin in human colonic epithelial cells Dig. Dis. Sci. 55 2010 1896 1904
16. A. Kitani, I.J. Fuss, K. Nakamura, O.M. Schwartz, T. Usui, and W. Strober Treatment of experimental (trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation J Exp Med 192 2000 41 52
17. F. Heller, I.J. Fuss, E.E. Nieuwenhuis, R.S. Blumberg, and W. Strober Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells Immunity 17 2002 629 638
18. M. Boirivant, I.J. Fuss, A. Chu, and W. Strober Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4 J Exp Med 188 1998 1929 1939
19. S. Ellison, K. Gabunia, J.M. Richards, S.E. Kelemen, R.N. England, D. Rudic, and et al. IL-19 reduces ligation-mediated neointimal hyperplasia by reducing vascular smooth muscle cell activation Am J Pathol 184 2014 2134 2143
20. I.J. Fuss, T. Marth, M.F. Neurath, G.R. Pearlstein, A. Jain, and W. Strober Anti-interleukin 12 treatment regulates apoptosis of Th1 cells in experimental colitis in mice Gastroenterology 117 1999 1078 1088
21. 2 + exchanger 2-heterozygote knockout mice display decreased acetylcholine release and altered colonic motility in vivo Neurogastroenterol. Motil. 24 2012 e600 e610
22. Y.T. Azuma, K. Nishiyama, Y. Matsuo, M. Kuwamura, A. Morioka, H. Nakajima, and et al. PPARα contributes to colonic protection in mice with DSS-induced colitis Int. Immunopharmacol. 10 2010 1261 1267
23. Y.T. Azuma, K. Hagi, N. Shintani, M. Kuwamura, H. Nakajima, H. Hashimoto, and et al. PACAP provides colonic protection against dextran sodium sulfate induced colitis J. Cell. Physiol. 216 2008 111 119
24. P. Brandtzaeg, G. Haraldsen, and J. Rugtveit Immunopathology of human inflammatory bowel disease Springer Semin. Immunopathol. 18 1997 555 589
25. W. Strober, I.J. Fuss, and R.S. Blumberg The immunology of mucosal models of inflammation Annu. Rev. Immunol. 20 2002 495 549
26. W. Strober, and I.J. Fuss Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases Gastroenterology 140 2011 1756 1767
27. A. Andoh, Z. Zhang, O. Inatomi, S. Fujino, Y. Deguchi, Y. Araki, and et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts Gastroenterology 129 2005 969 984
28. Smithgall MD, Comeau MR, Yoon BR, Kaufman D, Armitage R, Smith DE. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int. Immunol. 2008;20:1019-30.
29. P. Middel, P. Thelen, S. Blaschke, F. Polzien, K. Reich, V. Blaschke, and et al. Expression of the T-cell chemoattractant chemokine lymphotactin in Crohn's disease Am J Pathol 159 2001 1751 1761
30. E.Y. Lee, Z.H. Lee, and Y.W. Song CXCL10 and autoimmune diseases Autoimmun. Rev. 8 2009 379 383
31. H. Nakajima, M. Kobayashi, R.B. Pollard, and F. Suzuki Monocyte chemoattractant protein-1 enhances HSV-induced encephalomyelitis by stimulating Th2 responses J. Leukoc. Biol. 70 2001 374 380
32. E. Cantó, E. Garcia Planella, C. Zamora-Atenza, J.C. Nieto, J. Gordillo, M.A. Ortiz, and et al. Interleukin-19 impairment in active Crohn's disease patients PLoS One 9 2014 e93910
33. G. Fonseca-Camarillo, J. Furuzawa-Carballeda, J. Granados, and J.K. Yamamoto-Furusho Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study Clin. Exp. Immunol. 177 2014 64 75
34. L. Dumoutier, C. Leemans, D. Lejeune, S.V. Kotenko, and J.C. Renauld STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types J. Immunol. 167 2001 3545 3549
35. J. Parrish-Novak, W. Xu, T. Brender, L. Yao, C. Jones, J. West, and et al. Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions J. Biol. Chem. 277 2002 47517 47523
36. W.J. Jordan, J. Eskdale, M. Boniotto, G.P. Lennon, J. Peat, J.D. Campbell, and et al. Human IL-19 regulates immunity through auto-induction of IL-19 and production of IL-10 Eur. J. Immunol. 35 2005 1576 1582
37. C.H. Yeh, B.C. Cheng, C.C. Hsu, H.W. Chen, J.J. Wang, M.S. Chang, and et al. Induced interleukin-19 contributes to cell-mediated immunosuppression in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass Ann. Thorac. Surg. 92 2011 1252 1259
38. C. Wahl, W. Muller, F. Leithauser, G. Adler, F. Oswald, J. Reimann, and et al. IL-20 receptor 2 signaling down-regulates antigen-specific T cell responses J. Immunol. 182 2009 802 810
39. L.A. Dieleman, B.U. Ridwan, G.S. Tennyson, K.W. Beagley, R.P. Bucy, and C.O. Elson Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice Gastroenterology 107 1994 1643 1652